Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-117942

EVP, Head of North America sold 66,861 shares at an average $66.33 ($4,434,882)

  • EVP, Head of North America acquired 60,981 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise 10b5-1 +20,622 $6.80 $140,230 27,474 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise 10b5-1 +28,717 $24.29 $697,536 56,191 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise 10b5-1 +11,642 $30.66 $356,944 67,833 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Sale 10b5-1 −38,051 $65.68 $2,499,049 29,782 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Sale 10b5-1 −17,540 $66.95 $1,174,275 12,242 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Sale 10b5-1 −11,070 $67.56 $747,873 1,172 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Sale 10b5-1 −200 $68.43 $13,686 972 D
Derivatives
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −20,622 25,790 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −28,717 71,283 D
Lee Jennifer Kayden EVP, Head of North America 2024-11-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −11,642 37,108 D
Open-market sales · 66,861 sh · avg $66.33 · $4,434,882
Loading xslF345X05/tm2428383-1_4seq1.xml…